American Institute of Chemists names Ralph Hirschmann AIC Gold Medalist

PHILADELPHIA 11 April 2003 The American Institute of Chemists (AIC) and the Chemical Heritage Foundation (CHF) will present the 2003 AIC Gold Medal to Ralph F. Hirschmann. The award ceremony will be part of Heritage Day festivities at CHF in Philadelphia, Pennsylvania, on Thursday, 12 June 2003.

It is fitting that the first AIC Gold Medal awarded jointly by CHF and the AIC be presented to a pharmaceutical researcher with the talent, skills, and insight of Ralph Hirschmann, said Arnold Thackray, president of CHF. At Merck, he was head of the effort that developed effective drugs to treat hypertension, congestive heart failure, severe infection, river blindness in developing countries, and many other illnesses. His remarkable accomplishments as a researcher include the synthesis of the enzyme ribonuclease in solution, the first example of protein synthesis.

The presentation of the AIC Gold Medal will be part of a day devoted to celebrating the achievement and promise of the chemical and molecular sciences. Heritage Day begins with the awarding of the Othmer Gold Medal to John D. Baldeschwieler and George S. Hammond. In the late afternoon, Hirschmann will receive the AIC Gold Medal. Following a reception, the Winthrop-Sears Medal of The Chemists Club will be presented at a dinner at nearby Carpenters Hall.

Ralph F. Hirschmann
Ralph F. Hirschmann is Makineni Professor of Bioorganic Chemistry at the University of Pennsylvania. He joined the Penn faculty in 1987 after retiring as Mercks senior vice president of basic research. He was affiliated with Merck for 37 years, during which time he fostered interdisciplinary research as well as collaborations between academia and industry, practices he has continued at Penn.

Several widely used medications stem from Hirschmanns tenure at Merck, including the parasite-fighting Ivomec. And, in a major theoretical contribution to organic chemistry, he was the first to discover that chem

Contact: Neil Gussman
Chemical Heritage Foundation

Page: 1 2

Related biology news :

1. Highlights of the October 2004 Journal of the American Dietetic Association
2. The American Phytopathological Society announces 2004 awards
3. Tips from the Journals of the American Society for Microbiology
4. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
5. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
6. Tips from the journals of the American Society for Microbiology
7. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
8. More aggressive breast cancer tumors found in African American women
9. American Society of Mammalogists honors CI president Russell Mittermeier with Aldo Leopold award
10. Tips from the Journals of the American Society for Microbiology
11. Most Americans not sure about the sources of high cholesterol

Post Your Comments:

(Date:9/10/2015)... This report provides detailed descriptions of the ... emerging sensor types that will dominate in the future. ... the wearable technology hype curve in the last five ... feature with all of them is the prominence of ... useful functions. Sensors collect data about the physical and ...
(Date:9/10/2015)... Report Details The global wearable ... previous expectations of revenues, consumer adoption and even technological ... which wearables begin to achieve that mass market acceptance ... reasons is the entrance of Apple to the SmartWatches ... but the overall size of the wearable technology market. ...
(Date:9/10/2015)... Conn. , Sept. 10, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... based ecommerce site, Touch of Modern, will feature ... Wednesday, September 16 th . ... wide range of designer lifestyle products to its 7.2 ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... CORAL SPRINGS, Florida , October 13, 2015 /PRNewswire/ ... (OTCQX: AVXLD), Juno Therapeutics, Inc. (NASDAQ: JUNO ), ... --> ARRY ), Avanex Life Sciences Corp. (OTCQX: ... Progenix Pharmaceuticals, Inc. (NASDAQ: PGNX ) --> ... universities and the biotech industry can potentially lead to ...
(Date:10/13/2015)... , Oct. 13, 2015  According to ... services will reach $102 billion by the end ... of the health industry, as it is estimated ... result of laboratory tests. In addition to diagnosing ... to evaluate disease progression, monitor drug treatment and ...
(Date:10/13/2015)... ... October 13, 2015 , ... Proove Biosciences, a commercial ... with the Keck Medicine of the University of Southern California (USC) ... (Therapeutic Evaluation to Research Clinical Objectives Linking Genotypic and Phenotypic Association with Pain ...
(Date:10/12/2015)... Group, Inc. (NASDAQ: MDXG ), the leading regenerative ... to develop and market advanced products and therapies for ... and the Dental sectors of healthcare, announced today the ... Company has been dismissed by the court.  ... "As we suspected, this case was brought by an ...
Breaking Biology Technology:
Cached News: